Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels

Published:2019-07 Issue:7 Volume:21 Page:1497-1506
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Lee Kristy,Seifert Bryce A.,Shimelis Hermela,Ghosh Rajarshi,Crowley Stephanie B.,Carter Natalie J.,Doonanco Kurston,Foreman A. Katherine,Ritter Deborah I.,Jimenez Sharisse,Trapp Mackenzie,Offit Kenneth,Plon Sharon E.,Couch Fergus J.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-018-0361-5.pdf

Reference40 articles.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

2. Generating Clinical-Grade Gene–Disease Validity Classifications Through the ClinGen Data Platforms;Annual Review of Biomedical Data Science;2024-08-23

3. Medicolegal and insurance issues regardingBRCA1andBRCA2gene tests in high income countries;International Journal of Gynecologic Cancer;2024-04-19

4. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer;European Journal of Human Genetics;2024-03-05

5. Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review;Journal of Modern Oncology;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP